SELVAS Healthcare 将来の成長

Future 基準チェック /06

現在、 SELVAS Healthcareの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長	35.3%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing

Nov 11

Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)

Oct 25

SELVAS Healthcare (KOSDAQ:208370) Is Looking To Continue Growing Its Returns On Capital

Aug 27

Subdued Growth No Barrier To SELVAS Healthcare, Inc. (KOSDAQ:208370) With Shares Advancing 32%

Jul 30

We Think SELVAS Healthcare (KOSDAQ:208370) Can Manage Its Debt With Ease

Jul 25

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Mar 27

Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

Mar 11

SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

Jan 26

What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

Jan 03

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Dec 08

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、SELVAS Healthcare は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

KOSDAQ:A208370 - アナリストの将来予測と過去の財務データ ( )KRW Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	28,560	3,697	3,058	3,656	N/A
3/31/2024	29,547	5,055	2,141	2,658	N/A
12/31/2023	29,813	5,170	3,103	3,472	N/A
9/30/2023	29,232	2,913	3,084	3,343	N/A
6/30/2023	28,834	2,150	1,081	1,458	N/A
3/31/2023	28,160	2,902	887	1,286	N/A
12/31/2022	27,686	2,813	-310	51	N/A
9/30/2022	31,906	5,354	2,241	2,580	N/A
6/30/2022	31,930	6,375	2,466	2,640	N/A
3/31/2022	31,128	4,902	1,793	1,930	N/A
12/31/2021	29,089	2,472	2,552	2,928	N/A
9/30/2021	24,503	1,342	1,180	1,538	N/A
6/30/2021	22,574	-64	2,919	3,317	N/A
3/31/2021	20,619	-622	3,228	3,567	N/A
12/31/2020	21,152	759	4,086	4,227	N/A
9/30/2020	20,766	1,922	4,516	4,527	N/A
6/30/2020	21,509	786	3,434	3,413	N/A
3/31/2020	22,663	-817	4,535	4,580	N/A
12/31/2019	22,351	-3,328	3,616	3,686	N/A
9/30/2019	19,467	-19,302	2,023	2,196	N/A
6/30/2019	18,503	-20,703	-1,542	-1,008	N/A
3/31/2019	19,449	-19,885	-5,151	-4,315	N/A
12/31/2018	20,026	-19,992	-8,251	-6,898	N/A
9/30/2018	25,821	-6,553	-10,316	-7,252	N/A
6/30/2018	27,503	-4,496	-14,854	-7,743	N/A
3/31/2018	28,303	-3,779	N/A	-6,115	N/A
12/31/2017	29,576	-1,116	N/A	-4,303	N/A
9/30/2017	26,365	-4,694	N/A	-4,653	N/A
6/30/2017	24,360	-10,711	N/A	-4,656	N/A
3/31/2017	23,424	-15,070	N/A	-5,610	N/A
12/31/2016	23,087	-14,870	N/A	-6,226	N/A
9/30/2016	25,622	-8,648	N/A	-9,334	N/A
12/31/2015	20,854	2,137	N/A	-1,245	N/A

アナリストによる今後の成長予測

収入対貯蓄率: A208370の予測収益成長が貯蓄率 ( 2.7% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: A208370の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: A208370の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: A208370の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: A208370の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: A208370の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

SELVAS Healthcare 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Investor sentiment deteriorates as stock falls 18%

SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing

Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)

Now 20% overvalued after recent price rise

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

SELVAS Healthcare (KOSDAQ:208370) Is Looking To Continue Growing Its Returns On Capital

New minor risk - Share price stability

Subdued Growth No Barrier To SELVAS Healthcare, Inc. (KOSDAQ:208370) With Shares Advancing 32%

We Think SELVAS Healthcare (KOSDAQ:208370) Can Manage Its Debt With Ease

Investor sentiment improves as stock rises 22%

First quarter 2024 earnings released: EPS: ₩26.00 (vs ₩35.00 in 1Q 2023)

New minor risk - Market cap size

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

SELVAS Healthcare, Inc. has completed a Follow-on Equity Offering in the amount of KRW 20.876441 billion.

SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion.

SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion.

Investor sentiment deteriorates as stock falls 24%

Investor sentiment improves as stock rises 21%

Investor sentiment deteriorates as stock falls 31%

Investor sentiment improves as stock rises 35%

Investor sentiment improves as stock rises 27%

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: ₩81.00 loss per share (vs ₩17.00 loss in 1Q 2020)

Full year 2020 earnings released: EPS ₩35.00 (vs ₩239 loss in FY 2019)

Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

SELVAS Healthcare, Inc., Annual General Meeting, Mar 30, 2021

SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

New 90-day high: ₩2,595

What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

New 90-day high - ₩2,750

New 90-day low - ₩2,025

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘